Jane Street
BTAI icon

Jane Street’s BioXcel Therapeutics BTAI Stock Holding History

Jane Street’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-127,501
Closed -$204K – 11640
2025
Q4 		$204K Buy
+127,501
New +$263K ﹤0.01% 9682
2025
Q1 		– Sell
-1,459
Closed -$8.73K – 9476
2024
Q4 		$8.73K Sell
1,459
-1,623
-53% -$13.6K ﹤0.01% 9190
2024
Q3 		$30.1K Sell
3,082
-4,733
-61% -$63.6K ﹤0.01% 9250
2024
Q2 		$160K Buy
+7,815
New +$262K ﹤0.01% 8538
2024
Q1 		– Sell
-1,940
Closed -$91.6K – 9223
2023
Q4 		$91.6K Sell
1,940
-6,915
-78% -$384K ﹤0.01% 8617
2023
Q3 		$358K Buy
8,855
+2,544
+40% +$257K ﹤0.01% 6786
2023
Q2 		$672K Buy
6,311
+5,641
+842% +$1.88M ﹤0.01% 5857
2023
Q1 		$200K Buy
+670
New +$286K ﹤0.01% 7840
2022
Q4 		– Sell
-792
Closed -$150K – 9178
2022
Q3 		$150K Buy
+792
New +$184K ﹤0.01% 8396
2022
Q2 		– Sell
-4,875
Closed -$1.63M – 9697
2022
Q1 		$1.63M Buy
4,875
+3,410
+233% +$988K ﹤0.01% 5135
2021
Q4 		$476K Buy
1,465
+830
+131% +$356K ﹤0.01% 7355
2021
Q3 		$308K Sell
635
-371
-37% -$163K ﹤0.01% 8126
2021
Q2 		$468K Sell
1,006
-772
-43% -$421K ﹤0.01% 7370
2021
Q1 		$1.23M Buy
1,778
+48
+3% +$38.6K ﹤0.01% 5052
2020
Q4 		$1.28M Sell
1,730
-2,815
-62% -$2.19M ﹤0.01% 4265
2020
Q3 		$3.15M Buy
4,545
+4,199
+1,214% +$3.15M ﹤0.01% 2376
2020
Q2 		$294K Sell
346
-323
-48% -$211K ﹤0.01% 5862
2020
Q1 		$239K Buy
+669
New +$240K ﹤0.01% 4463

Other funds holding BTAI

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jane Street's BTAI Position: Q1 2026 in Review

Jane Street sold out of BioXcel Therapeutics (BTAI) in Q1 2026, closing a stake of 127,501 shares — an estimated $204K sold.

Jane Street first reported a position in BTAI in Q1 2020 and held it in 18 quarters. The position peaked at $3.15M in Q3 2020. 40 funds tracked by Wall St. Rank hold BTAI as of Q1 2026.

  • Jane Street reported no remaining BioXcel Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 127,501 BioXcel Therapeutics shares in Q1 2026, an estimated $204K.
  • Jane Street first reported a position in BioXcel Therapeutics in Q1 2020 and held it in 18 quarters.
  • Jane Street's BioXcel Therapeutics position peaked at $3.15M in Q3 2020.
  • 40 funds tracked by Wall St. Rank held BioXcel Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.